Next Generation
Biomanufacturing
We are combining the scalability of biochemistry and the adaptability of enzyme biology, into the next generation of biomanufacturing via our cell-free technology platform.
The Invizyne Purpose
We are building the next generation biomanufacturing platform for the efficient, sustainable and environmentally friendly production of the fuels, foods, medicines, and other chemical products needed to satisfy the world’s growing population.
The Invizyne Solution
First generation Synthetic Biology promised to provide environmentally friendly chemical manufacturing by using engineered living cells, but the solutions were rarely effective or scalable. Invizyne has pioneered Cell-Free Biomanufacturing, which is significantly more effective because it liberates chemical manufacturing from biological constraints.
TECHNOLOGY
In an ideal world, we would use nature’s catalysts - enzymes - to make chemicals. Enzymes can produce chemicals with remarkable efficiency and without toxic waste, yet so far enzyme-based manufacturing has been quite limited. Invizyne’s cell-free technology greatly expands our ability to perform enzyme-based conversions, ushering in a new generation of sustainable biomanufacturing.
​
Invizyne cell-free solutions have proven effective for producing
​
-
Natural ingredients
Next generation flavors, fragrances, nutraceuticals
-
Pharmaceuticals
Drugs compounds both better and new-to-nature (and new-to-chemistry), see our example with making cannabinoids.
-
Specialty Chemicals & Biofuels
See our examples of Isobutanol for use for both Renewable Chemicals or Sustainable Aviation Fuel (SAF)
SCIENTIFIC VALIDATION
Invizyne's pioneering work in cell-free biomanufacturing has been published multiple times in peer-reviewed high-impact journals.
PATENTED TECHNOLOGY
In addition to multiple patents currently pending, Invizyne's scientific foundation is already resting on multiple issued patents, including the ones listed below.
-
Synthetic biochemistry molecular purge valve module that maintain co-factor balance
-
Cell-free metabolic pathway for glucose metabolism with a molecular purge valve
-
Biosynthetic platform for the production of cannabinoids and other prenylated compounds
-
Biosynthesis of cyclolavandulyl derivatives of aromatic compounds
MARKETS & PRODUCTS
Invizyne's pioneering platform has been applied to produce a wide variety of high value and difficult to make target molecules, with exceptional success in cannabinoids, biofuels and terpenes, where we’ve achieved orders of magnitude higher concentrations than what is possible using yeast-based methods.
​
Contact us to learn more on how we can provide solutions for:
​
-
Natural Ingredients: cannabinoids, flavor enhancers for food and beverage products, fragrances, nutraceuticals, organic compounds​
-
Pharmaceuticals: natural products with therapeutic properties
-
Chemicals: commodity chemicals, specialty chemicals, biofuels
​
​
Invizyne's founder story
LEADERSHIP
Our team combines decades of experience in biochemistry, biophysics, molecular biology, engineering, with sound and innovative business practices and principles.
​
MICHAEL HELTZEN
CEO
​
TYLER KORMAN, PhD
Co-Founder & VP of Research
PAUL OPGENORTH, PhD
Co-Founder & VP of Development
​
_edited.png)
FOUAD NAWAZ
VP of Finance
ZACHARY KARL, PhD
VP of Business Development​
MICHAEL BURNS
VP of Energy Transition​
LASSE H. GÖRLITZ
VP of Communications
Board of Directors
MO HAYAT
Chairman & Co-Founder
ANTHONY DiGIANDOMENICO
Board Member​
CHRISTOPHER MARLETT
Board Member​
JIM LALONDE, PhD
Board Member
Formerly SVP of R&D at Codexis
​
LON BELL
Board Member
​
Scientific Advisory Board
JAMES BOWIE, PhD
Co-Founder & Board Member
Professor Emeritus, Dept of Chemistry and Biochemistry at UCLA
​
YI TANG, PhD
Chancellor Professor at UCLA
​